Masimo (MASI) Net Cash Flow Growth (1y) (2011 - 2026)
Masimo (MASI) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.81 Bn | 99.59 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.39 Bn | 66.94 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 48.28 Bn | 44.60 Bn | 1.29 Bn | -564.44% |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | -31.84% |
| 7 | GE HealthCare Technologies | 28.30 Bn | 26.01 Bn | 1.98 Bn | -394.13% |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | 76.43% |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | -430.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -430.77% |
| Jan 3, 2026 | -365.58% |
| Sep 27, 2025 | -1,516.83% |
| Jun 28, 2025 | 494.29% |
| Mar 29, 2025 | -405.88% |
| Dec 28, 2024 | 206.50% |
| Sep 28, 2024 | 0.00% |
| Jun 29, 2024 | -89.19% |
| Mar 30, 2024 | 103.70% |
| Dec 30, 2023 | 158.65% |
| Sep 30, 2023 | -131.56% |
| Jul 1, 2023 | 99.23% |
| Apr 1, 2023 | -100.44% |
| Dec 31, 2022 | -83,270.73% |
| Apr 2, 2022 | 74.85% |
| Apr 3, 2021 | -338.30% |
| Sep 26, 2020 | -65.29% |
| Jun 27, 2020 | 793.35% |
| Mar 28, 2020 | 127.42% |
| Dec 28, 2019 | -11.70% |